J. Russel Denton - 07 Nov 2025 Form 4 Insider Report for Caris Life Sciences, Inc.

Role
Senior Vice President, General Counsel, and Secretary
Signature
/s/ J. Russel Denton
Issuer symbol
CAI on Nasdaq
Transactions as of
07 Nov 2025
Net transactions value
+$100,793
Form type
4
Filing time
10 Nov 2025, 08:12:42 UTC
Previous filing
17 Jun 2025
Next filing
10 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Denton John Russel Senior Vice President, General Counsel, and Secretary C/O CARIS LIFE SCIENCES, INC., 750 W. JOHN CARPENTER FREEWAY, SUITE 800, IRVING /s/ J. Russel Denton 10 Nov 2025 0002071923

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CAI Common Stock Purchase $100,793 +4,184 +84% $24.09 9,184 07 Nov 2025 By Trust F1
holding CAI Common Stock 123,591 07 Nov 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.99 to $24.15, inclusive. The reporting person undertakes to provide to Caris Life Sciences, Inc., any security holder of Caris Life Sciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Remarks:

Senior Vice President, General Counsel, and Secretary